MENU
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Arcus Biosciences (RCUS) Earnings Date & Reports

A.I. Advisor
published Earnings

RCUS is expected to report earnings to rise 17.00% to -116 cents per share on February 19

Arcus Biosciences RCUS Stock Earnings Reports
Q4'24
Est.
$-1.17
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.95
Q4'23
Missed
by $0.06
The last earnings report on November 06 showed earnings per share of -100 cents, beating the estimate of -101 cents. With 472.65K shares outstanding, the current market capitalization sits at 1.44B.
View a ticker or compare two or three
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com